Cargando…

Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies

A library of variously decorated N-phenyl secondary sulphonamides featuring the bicyclic tetrahydroquinazole scaffold was synthesised and biologically evaluated for their inhibitory activity against human carbonic anhydrase (hCA) I, II, IV, and IX. Of note, several compounds were identified showing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baglini, Emma, Ravichandran, Rahul, Berrino, Emanuela, Salerno, Silvia, Barresi, Elisabetta, Marini, Anna Maria, Viviano, Monica, Castellano, Sabrina, Da Settimo, Federico, Supuran, Claudiu T., Cosconati, Sandro, Taliani, Sabrina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344263/ https://www.ncbi.nlm.nih.gov/pubmed/34340614 http://dx.doi.org/10.1080/14756366.2021.1956913

Ejemplares similares

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
por: Milite, Ciro, et al.
Publicado: (2019)

Carbonic anhydrase activation profile of indole-based derivatives
por: Barresi, Elisabetta, et al.
Publicado: (2021)

Carbonic Anhydrase Activators for Neurodegeneration: An Overview
por: Poggetti, Valeria, et al.
Publicado: (2022)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
por: Koyuncu, Ismail, et al.
Publicado: (2019)

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023)

A class of carbonic anhydrase IX/XII – selective carboxylate inhibitors
por: Alhameed, Rakia Abd, et al.
Publicado: (2020)

The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
por: Robello, Marco, et al.
Publicado: (2021)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
por: Salerno, Silvia, et al.
Publicado: (2023)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
por: Abdelrahman, Mohamed A., et al.
Publicado: (2019)

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors
por: Güzel-Akdemir, Özlen, et al.
Publicado: (2018)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
por: Sethi, Kalyan K., et al.
Publicado: (2021)

Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies
por: Gualtieri, Gianmarco, et al.
Publicado: (2023)

Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase
por: Urbanski, Linda J., et al.
Publicado: (2020)

Structural Insights into Carbonic Anhydrase IX Isoform Specificity of Carbohydrate-Based Sulfamates
por: Moeker, Janina, et al.
Publicado: (2014)

Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
por: Koyuncu, Ismail, et al.
Publicado: (2018)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
por: Krasavin, Mikhail, et al.
Publicado: (2020)

Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives
por: Shilkar, Deepak, et al.
Publicado: (2023)

Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors
por: Del Prete, Sonia, et al.
Publicado: (2020)

Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosisβ-class enzyme Rv3273
por: Wani, Tanvi V., et al.
Publicado: (2018)

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
por: Vullo, Daniela, et al.
Publicado: (2017)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
por: Seršen, Sara, et al.
Publicado: (2019)

Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides
por: Urbański, Linda J., et al.
Publicado: (2020)

The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII
por: Bonardi, Alessandro, et al.
Publicado: (2022)

Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
por: Rogato, Alessandra, et al.
Publicado: (2019)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
por: Astrain-Redin, Nora, et al.
Publicado: (2023)

Carbonic anhydrase IX as a novel candidate in liquid biopsy
por: Ozensoy Guler, Ozen, et al.
Publicado: (2019)

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
por: Abutaleb, Nader S., et al.
Publicado: (2021)

Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species
por: da Silva Cardoso, Verônica, et al.
Publicado: (2018)

Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors
por: Shaldam, Moataz, et al.
Publicado: (2021)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties
por: Bilginer, Sinan, et al.
Publicado: (2019)

Novel positive allosteric modulators of A(2B) adenosine receptor acting as bone mineralisation promoters
por: Barresi, Elisabetta, et al.
Publicado: (2020)

Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration
por: Corsi, Francesca, et al.
Publicado: (2022)

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012)

Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid–sulphonamide conjugates
por: Küçükbay, Hasan, et al.
Publicado: (2020)

Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides
por: Monti, Simona Maria, et al.
Publicado: (2017)

Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation
por: Brichet, Jeremie, et al.
Publicado: (2020)

In Silico Identification and Biological Evaluation of Antioxidant Food Components Endowed with Human Carbonic Anhydrase IX and XII Inhibition
por: Costa, Giosuè, et al.
Publicado: (2020)

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII
por: Balašova, Anastasija, et al.
Publicado: (2023)

Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages
por: Berrino, Emanuela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn396mu2bnldh6csebl8fgmn34